This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Natalie Boytsov, PhD
Advertisement
Articles by Natalie Boytsov, PhD
We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Advertisement
Latest Updated Articles
- Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources
Published: February 26th 2015 | Updated:
- Daily Dose and Costs of Therapy With Topical Testosterone Agents
Published: December 16th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
4
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
5
